Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

This study has been completed.
Information provided by (Responsible Party):
NeuroDerm Ltd. Identifier:
First received: October 3, 2010
Last updated: December 4, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)